| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2018 | 584 | 2.08 | Why? |
| Mouth Mucosa | 3 | 2018 | 323 | 1.71 | Why? |
| Transgenes | 3 | 2018 | 227 | 1.49 | Why? |
| Tumor Suppressor Proteins | 3 | 2018 | 165 | 1.47 | Why? |
| Ectodermal Dysplasia | 2 | 2018 | 39 | 1.43 | Why? |
| Cleft Lip | 2 | 2018 | 76 | 1.32 | Why? |
| Cleft Palate | 2 | 2018 | 81 | 1.30 | Why? |
| Transcription Factors | 4 | 2018 | 784 | 1.08 | Why? |
| Cell Culture Techniques | 2 | 2018 | 704 | 1.02 | Why? |
| Stem Cells | 2 | 2018 | 595 | 0.93 | Why? |
| Oncolytic Viruses | 1 | 2019 | 20 | 0.81 | Why? |
| Oncolytic Virotherapy | 1 | 2019 | 36 | 0.80 | Why? |
| Enterobiasis | 1 | 2018 | 4 | 0.76 | Why? |
| Japanese Encephalitis Vaccines | 1 | 2018 | 14 | 0.75 | Why? |
| Listeriosis | 1 | 2018 | 36 | 0.73 | Why? |
| DNA, Viral | 10 | 2018 | 2521 | 0.72 | Why? |
| Human Activities | 1 | 2020 | 293 | 0.72 | Why? |
| Encephalitis Virus, Japanese | 1 | 2018 | 63 | 0.72 | Why? |
| Plasmodium knowlesi | 1 | 2017 | 11 | 0.71 | Why? |
| Listeria monocytogenes | 1 | 2018 | 68 | 0.71 | Why? |
| Lymphadenitis | 1 | 2018 | 53 | 0.71 | Why? |
| Encephalitis, Japanese | 1 | 2018 | 58 | 0.70 | Why? |
| Stomatitis, Aphthous | 1 | 2018 | 43 | 0.70 | Why? |
| Herpesvirus 8, Human | 3 | 2018 | 97 | 0.69 | Why? |
| Virus Diseases | 5 | 2018 | 3779 | 0.68 | Why? |
| Cytomegalovirus | 7 | 2019 | 600 | 0.66 | Why? |
| Amiodarone | 1 | 2018 | 110 | 0.65 | Why? |
| Anal Canal | 1 | 2019 | 367 | 0.61 | Why? |
| Epithelial Cells | 2 | 2018 | 3508 | 0.59 | Why? |
| Schools | 2 | 2021 | 4187 | 0.57 | Why? |
| Embryoid Bodies | 3 | 2018 | 9 | 0.56 | Why? |
| Surface-Active Agents | 1 | 2017 | 267 | 0.56 | Why? |
| Papillomavirus Infections | 3 | 2019 | 861 | 0.55 | Why? |
| Mouth | 1 | 2019 | 622 | 0.54 | Why? |
| Central Nervous System Infections | 1 | 2016 | 158 | 0.53 | Why? |
| Pharyngitis | 1 | 2018 | 687 | 0.52 | Why? |
| Biological Therapy | 1 | 2018 | 456 | 0.52 | Why? |
| Cytomegalovirus Infections | 7 | 2019 | 667 | 0.50 | Why? |
| Homosexuality, Male | 2 | 2019 | 1158 | 0.50 | Why? |
| Gene Expression Regulation, Bacterial | 3 | 2017 | 143 | 0.50 | Why? |
| Cell Differentiation | 2 | 2018 | 1338 | 0.49 | Why? |
| Semen | 2 | 2018 | 550 | 0.49 | Why? |
| Cellular Reprogramming | 3 | 2018 | 117 | 0.48 | Why? |
| Off-Label Use | 1 | 2017 | 553 | 0.47 | Why? |
| Herpesviridae Infections | 3 | 2018 | 172 | 0.47 | Why? |
| Adrenal Gland Neoplasms | 3 | 2007 | 70 | 0.46 | Why? |
| Zika Virus Infection | 4 | 2018 | 1920 | 0.46 | Why? |
| Klebsiella Infections | 2 | 2017 | 466 | 0.45 | Why? |
| Virus Attachment | 2 | 2020 | 1259 | 0.45 | Why? |
| beta-Lactamases | 3 | 2018 | 759 | 0.45 | Why? |
| Celiac Disease | 1 | 2017 | 471 | 0.43 | Why? |
| Mutation | 9 | 2021 | 12376 | 0.43 | Why? |
| Ebolavirus | 1 | 2018 | 834 | 0.43 | Why? |
| Klebsiella pneumoniae | 2 | 2017 | 658 | 0.42 | Why? |
| G-Quadruplexes | 3 | 2017 | 126 | 0.42 | Why? |
| BCG Vaccine | 1 | 2020 | 1137 | 0.40 | Why? |
| Italy | 17 | 2021 | 38444 | 0.39 | Why? |
| Viruses | 4 | 2018 | 2238 | 0.38 | Why? |
| Immediate-Early Proteins | 2 | 2019 | 44 | 0.37 | Why? |
| Bacterial Proteins | 6 | 2018 | 1318 | 0.37 | Why? |
| Polyomavirus Infections | 2 | 2007 | 156 | 0.37 | Why? |
| Tumor Virus Infections | 2 | 2007 | 127 | 0.37 | Why? |
| Melanoma | 1 | 2019 | 1229 | 0.36 | Why? |
| Oncogene Proteins, Viral | 2 | 2018 | 36 | 0.35 | Why? |
| Host-Pathogen Interactions | 4 | 2020 | 11041 | 0.35 | Why? |
| Antimalarials | 2 | 2017 | 2505 | 0.35 | Why? |
| Single-Cell Analysis | 1 | 2018 | 2450 | 0.35 | Why? |
| Polyomavirus | 1 | 2007 | 37 | 0.35 | Why? |
| Gastrointestinal Motility | 2 | 2018 | 78 | 0.34 | Why? |
| Malaria | 1 | 2017 | 1097 | 0.33 | Why? |
| Trans-Activators | 2 | 2019 | 170 | 0.33 | Why? |
| Herpes Simplex | 4 | 2018 | 272 | 0.33 | Why? |
| Herpesviridae | 1 | 2007 | 100 | 0.32 | Why? |
| Macrophages | 4 | 2018 | 2784 | 0.30 | Why? |
| Thymidine Kinase | 1 | 2005 | 11 | 0.30 | Why? |
| Students | 2 | 2021 | 5255 | 0.30 | Why? |
| Antiviral Agents | 15 | 2021 | 41703 | 0.30 | Why? |
| HIV Infections | 9 | 2019 | 11620 | 0.29 | Why? |
| Zoonoses | 1 | 2019 | 3034 | 0.29 | Why? |
| Promoter Regions, Genetic | 3 | 2017 | 823 | 0.29 | Why? |
| Seroepidemiologic Studies | 2 | 2020 | 10017 | 0.29 | Why? |
| Anti-Arrhythmia Agents | 2 | 2018 | 325 | 0.28 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2012 | 1115 | 0.27 | Why? |
| Herpesvirus 4, Human | 2 | 2018 | 387 | 0.27 | Why? |
| Plasmids | 3 | 2018 | 840 | 0.26 | Why? |
| Mycobacterium tuberculosis | 3 | 2017 | 1164 | 0.26 | Why? |
| Animals | 25 | 2021 | 78931 | 0.25 | Why? |
| Hepatitis C, Chronic | 3 | 2018 | 973 | 0.25 | Why? |
| Cell Line | 7 | 2018 | 12040 | 0.25 | Why? |
| Vaginal Neoplasms | 1 | 2002 | 39 | 0.25 | Why? |
| Virus Internalization | 4 | 2020 | 7921 | 0.24 | Why? |
| Viremia | 4 | 2018 | 1020 | 0.24 | Why? |
| Pyridines | 2 | 2018 | 680 | 0.24 | Why? |
| Zika Virus | 4 | 2018 | 1924 | 0.23 | Why? |
| Nuclear Localization Signals | 2 | 2018 | 85 | 0.23 | Why? |
| Humans | 77 | 2021 | 930598 | 0.23 | Why? |
| Carcinoma | 1 | 2005 | 256 | 0.23 | Why? |
| Drug Repositioning | 2 | 2018 | 5683 | 0.22 | Why? |
| Enteric Nervous System | 2 | 2018 | 28 | 0.22 | Why? |
| Precancerous Conditions | 1 | 2002 | 108 | 0.22 | Why? |
| Transcriptional Activation | 2 | 2019 | 196 | 0.22 | Why? |
| Active Transport, Cell Nucleus | 2 | 2018 | 203 | 0.22 | Why? |
| Fever | 1 | 2018 | 7795 | 0.22 | Why? |
| Administration, Intravesical | 1 | 2020 | 94 | 0.22 | Why? |
| Hysterectomy | 1 | 2002 | 171 | 0.21 | Why? |
| Sendai virus | 2 | 2018 | 111 | 0.21 | Why? |
| Herpesvirus 1, Human | 3 | 2018 | 286 | 0.21 | Why? |
| Genetic Therapy | 1 | 2005 | 409 | 0.21 | Why? |
| Sequence Analysis, DNA | 3 | 2018 | 2830 | 0.20 | Why? |
| Orthomyxoviridae | 2 | 2019 | 1168 | 0.20 | Why? |
| Receptors, Cell Surface | 2 | 2018 | 586 | 0.20 | Why? |
| Cells, Cultured | 6 | 2019 | 5835 | 0.20 | Why? |
| Carcinoma, Verrucous | 1 | 2018 | 8 | 0.20 | Why? |
| Thyroid Neoplasms | 1 | 2005 | 422 | 0.19 | Why? |
| Symbiosis | 1 | 2018 | 38 | 0.19 | Why? |
| Tumor Suppressor Protein p53 | 2 | 2018 | 310 | 0.19 | Why? |
| Viral Proteins | 5 | 2021 | 7370 | 0.19 | Why? |
| Repressor Proteins | 2 | 2018 | 232 | 0.19 | Why? |
| Cell Nucleus | 2 | 2018 | 399 | 0.19 | Why? |
| Sigma Factor | 1 | 2017 | 2 | 0.19 | Why? |
| Spectrophotometry, Ultraviolet | 1 | 2018 | 81 | 0.19 | Why? |
| F-Box Proteins | 1 | 2018 | 13 | 0.18 | Why? |
| Karyotyping | 1 | 2018 | 52 | 0.18 | Why? |
| Papillomavirus E7 Proteins | 1 | 2018 | 20 | 0.18 | Why? |
| alpha Karyopherins | 1 | 2018 | 44 | 0.18 | Why? |
| Jumonji Domain-Containing Histone Demethylases | 1 | 2018 | 28 | 0.18 | Why? |
| Karyopherins | 1 | 2018 | 38 | 0.18 | Why? |
| Genetics, Microbial | 1 | 2017 | 9 | 0.18 | Why? |
| Genes, Essential | 1 | 2017 | 34 | 0.18 | Why? |
| Ethambutol | 1 | 2017 | 34 | 0.18 | Why? |
| Saccharomyces boulardii | 1 | 2017 | 5 | 0.18 | Why? |
| Genome, Fungal | 1 | 2017 | 26 | 0.18 | Why? |
| Atovaquone | 1 | 2017 | 19 | 0.18 | Why? |
| Berberine | 1 | 2019 | 98 | 0.18 | Why? |
| Dihydropyridines | 1 | 2017 | 29 | 0.18 | Why? |
| Proguanil | 1 | 2017 | 23 | 0.18 | Why? |
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 43 | 0.18 | Why? |
| Terminal Repeat Sequences | 1 | 2017 | 13 | 0.18 | Why? |
| Reoviridae | 1 | 2017 | 26 | 0.18 | Why? |
| Biomarkers | 3 | 2018 | 23361 | 0.18 | Why? |
| Imides | 1 | 2017 | 10 | 0.18 | Why? |
| Papillomaviridae | 1 | 2002 | 404 | 0.17 | Why? |
| Membrane Transport Modulators | 1 | 2017 | 11 | 0.17 | Why? |
| Tissue Distribution | 1 | 2019 | 483 | 0.17 | Why? |
| Drug Tolerance | 1 | 2017 | 100 | 0.17 | Why? |
| Human papillomavirus 16 | 1 | 2018 | 95 | 0.17 | Why? |
| Heterografts | 1 | 2017 | 203 | 0.17 | Why? |
| HIV Integrase | 1 | 2017 | 67 | 0.17 | Why? |
| Naphthalenes | 1 | 2017 | 94 | 0.17 | Why? |
| Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 198 | 0.17 | Why? |
| Encephalitis, Varicella Zoster | 1 | 2016 | 9 | 0.16 | Why? |
| Cellular Reprogramming Techniques | 1 | 2017 | 43 | 0.16 | Why? |
| Thiophenes | 1 | 2017 | 78 | 0.16 | Why? |
| Herpesvirus 7, Human | 1 | 2016 | 18 | 0.16 | Why? |
| HIV-1 | 6 | 2018 | 3365 | 0.16 | Why? |
| Radiotherapy | 1 | 2002 | 608 | 0.16 | Why? |
| Encephalitis, Herpes Simplex | 1 | 2016 | 26 | 0.16 | Why? |
| Mutant Proteins | 1 | 2017 | 328 | 0.16 | Why? |
| Parechovirus | 1 | 2016 | 48 | 0.16 | Why? |
| Virus Physiological Phenomena | 1 | 2018 | 155 | 0.16 | Why? |
| Parvovirus B19, Human | 1 | 2016 | 73 | 0.15 | Why? |
| Tissue Scaffolds | 1 | 2017 | 174 | 0.15 | Why? |
| Transcriptome | 3 | 2018 | 3466 | 0.15 | Why? |
| Neck | 1 | 2018 | 307 | 0.15 | Why? |
| Tissue Engineering | 1 | 2017 | 190 | 0.15 | Why? |
| Membrane Transport Proteins | 1 | 2017 | 152 | 0.15 | Why? |
| Lentivirus | 1 | 2017 | 310 | 0.15 | Why? |
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2018 | 214 | 0.15 | Why? |
| Base Sequence | 5 | 2017 | 3581 | 0.15 | Why? |
| Mutagenesis | 1 | 2017 | 394 | 0.15 | Why? |
| DNA Mutational Analysis | 1 | 2018 | 581 | 0.15 | Why? |
| RNA, Viral | 6 | 2018 | 32276 | 0.15 | Why? |
| Lipopolysaccharide Receptors | 1 | 2018 | 357 | 0.15 | Why? |
| Molecular Biology | 1 | 2017 | 139 | 0.15 | Why? |
| Antigens, CD | 2 | 2018 | 984 | 0.14 | Why? |
| Molecular Sequence Data | 3 | 2012 | 3198 | 0.14 | Why? |
| Luminescent Measurements | 1 | 2020 | 924 | 0.14 | Why? |
| Adenoviridae Infections | 1 | 2016 | 150 | 0.14 | Why? |
| Organoids | 2 | 2018 | 840 | 0.14 | Why? |
| Roseolovirus Infections | 1 | 2016 | 131 | 0.14 | Why? |
| Endocytosis | 1 | 2018 | 451 | 0.14 | Why? |
| Irritable Bowel Syndrome | 1 | 2017 | 175 | 0.14 | Why? |
| Conserved Sequence | 1 | 2017 | 751 | 0.14 | Why? |
| Sterilization | 1 | 2017 | 294 | 0.14 | Why? |
| Philippines | 1 | 2017 | 568 | 0.14 | Why? |
| Spatio-Temporal Analysis | 1 | 2021 | 1182 | 0.14 | Why? |
| Sustained Virologic Response | 1 | 2016 | 378 | 0.14 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2018 | 669 | 0.14 | Why? |
| Amino Acids | 1 | 2018 | 552 | 0.14 | Why? |
| Farmers | 1 | 2017 | 280 | 0.14 | Why? |
| HEK293 Cells | 5 | 2018 | 8394 | 0.14 | Why? |
| DNA Footprinting | 1 | 2013 | 10 | 0.14 | Why? |
| Parvoviridae Infections | 1 | 2016 | 222 | 0.13 | Why? |
| Drug Resistance, Viral | 2 | 2019 | 1083 | 0.13 | Why? |
| Herpesvirus 6, Human | 1 | 2016 | 162 | 0.13 | Why? |
| Triazoles | 1 | 2018 | 440 | 0.13 | Why? |
| Gene Editing | 1 | 2017 | 330 | 0.13 | Why? |
| Mice | 7 | 2018 | 21357 | 0.13 | Why? |
| Proteolysis | 1 | 2018 | 751 | 0.13 | Why? |
| Genome, Bacterial | 1 | 2017 | 446 | 0.13 | Why? |
| Hepatitis E virus | 1 | 2017 | 306 | 0.13 | Why? |
| Herpesvirus 3, Human | 1 | 2016 | 228 | 0.13 | Why? |
| Respiratory Syncytial Viruses | 1 | 2018 | 612 | 0.13 | Why? |
| Urinary Bladder Neoplasms | 1 | 2020 | 614 | 0.13 | Why? |
| Genetic Vectors | 2 | 2018 | 1600 | 0.13 | Why? |
| Papillomavirus Vaccines | 1 | 2019 | 405 | 0.13 | Why? |
| Blood | 1 | 2014 | 274 | 0.13 | Why? |
| Nitriles | 1 | 2018 | 1053 | 0.13 | Why? |
| Esophageal Neoplasms | 1 | 2018 | 357 | 0.13 | Why? |
| MicroRNAs | 2 | 2018 | 1787 | 0.13 | Why? |
| Hepatitis E | 1 | 2017 | 319 | 0.13 | Why? |
| Syndrome | 1 | 2018 | 1310 | 0.12 | Why? |
| Uterine Cervical Neoplasms | 2 | 2018 | 842 | 0.12 | Why? |
| Immune Tolerance | 1 | 2017 | 608 | 0.12 | Why? |
| Cluster Analysis | 1 | 2021 | 3001 | 0.12 | Why? |
| Enterobacteriaceae Infections | 1 | 2018 | 529 | 0.12 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.12 | Why? |
| Enterovirus | 1 | 2016 | 402 | 0.12 | Why? |
| Child, Preschool | 5 | 2021 | 36283 | 0.12 | Why? |
| Female | 26 | 2020 | 380317 | 0.12 | Why? |
| Psychotropic Drugs | 1 | 2017 | 396 | 0.12 | Why? |
| Protein Multimerization | 1 | 2018 | 1336 | 0.11 | Why? |
| Epstein-Barr Virus Infections | 1 | 2016 | 366 | 0.11 | Why? |
| CRISPR-Cas Systems | 2 | 2018 | 1397 | 0.11 | Why? |
| Neurons | 1 | 2018 | 864 | 0.11 | Why? |
| Pneumococcal Vaccines | 1 | 2017 | 571 | 0.11 | Why? |
| Enterovirus Infections | 1 | 2016 | 404 | 0.11 | Why? |
| Middle Aged | 17 | 2021 | 270681 | 0.11 | Why? |
| Asia | 1 | 2018 | 2399 | 0.11 | Why? |
| Antitubercular Agents | 1 | 2017 | 775 | 0.11 | Why? |
| Pneumococcal Infections | 1 | 2017 | 562 | 0.11 | Why? |
| Mastitis, Bovine | 1 | 2009 | 3 | 0.11 | Why? |
| Virus Replication | 7 | 2019 | 14331 | 0.11 | Why? |
| Staphylococcal Vaccines | 1 | 2009 | 13 | 0.11 | Why? |
| Picornaviridae Infections | 1 | 2016 | 544 | 0.11 | Why? |
| Herpes Genitalis | 1 | 2011 | 90 | 0.10 | Why? |
| Adhesins, Bacterial | 1 | 2009 | 39 | 0.10 | Why? |
| Coagulase | 1 | 2009 | 44 | 0.10 | Why? |
| Incidence | 3 | 2021 | 25622 | 0.10 | Why? |
| Anti-Bacterial Agents | 1 | 2012 | 10083 | 0.10 | Why? |
| Orexin Receptors | 1 | 2009 | 6 | 0.10 | Why? |
| Herpesvirus 2, Human | 1 | 2011 | 137 | 0.10 | Why? |
| Infant, Newborn | 4 | 2021 | 23105 | 0.10 | Why? |
| Male | 22 | 2020 | 367725 | 0.10 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.10 | Why? |
| Small Molecule Libraries | 1 | 2018 | 1060 | 0.10 | Why? |
| Adenoviridae | 1 | 2016 | 1151 | 0.10 | Why? |
| Interleukin-1alpha | 1 | 2009 | 42 | 0.10 | Why? |
| Viral Matrix Proteins | 1 | 2018 | 1243 | 0.10 | Why? |
| Probiotics | 1 | 2017 | 694 | 0.10 | Why? |
| Evolution, Molecular | 2 | 2021 | 3691 | 0.10 | Why? |
| Longitudinal Studies | 3 | 2019 | 9893 | 0.09 | Why? |
| Myenteric Plexus | 2 | 2018 | 5 | 0.09 | Why? |
| Hospitals, Teaching | 1 | 2017 | 1609 | 0.09 | Why? |
| Coculture Techniques | 1 | 2009 | 258 | 0.09 | Why? |
| Adult | 15 | 2021 | 244371 | 0.09 | Why? |
| DNA Primers | 2 | 2013 | 1170 | 0.09 | Why? |
| Influenza A virus | 2 | 2019 | 2234 | 0.09 | Why? |
| Transduction, Genetic | 1 | 2009 | 273 | 0.09 | Why? |
| Antigens, Viral, Tumor | 1 | 2007 | 7 | 0.09 | Why? |
| Molecular Targeted Therapy | 1 | 2017 | 1579 | 0.09 | Why? |
| Cytokines | 3 | 2017 | 15010 | 0.09 | Why? |
| DNA, Bacterial | 1 | 2012 | 835 | 0.09 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2018 | 1234 | 0.09 | Why? |
| Antigens, Surface | 1 | 2009 | 181 | 0.09 | Why? |
| Viral Tropism | 1 | 2016 | 1329 | 0.09 | Why? |
| Chiroptera | 2 | 2021 | 3530 | 0.09 | Why? |
| Cattle | 3 | 2020 | 1336 | 0.09 | Why? |
| Hepatitis B, Chronic | 1 | 2015 | 616 | 0.09 | Why? |
| Heart | 1 | 2017 | 1791 | 0.09 | Why? |
| Anti-Retroviral Agents | 1 | 2016 | 1099 | 0.09 | Why? |
| Antifungal Agents | 1 | 2018 | 1828 | 0.09 | Why? |
| Autoimmune Diseases | 1 | 2021 | 1996 | 0.08 | Why? |
| Drug Combinations | 1 | 2017 | 3852 | 0.08 | Why? |
| Dogs | 3 | 2020 | 2529 | 0.08 | Why? |
| Phagocytosis | 1 | 2009 | 409 | 0.08 | Why? |
| Adrenocortical Adenoma | 1 | 2006 | 5 | 0.08 | Why? |
| Cell Migration Inhibition | 1 | 2006 | 1 | 0.08 | Why? |
| Virulence Factors | 1 | 2009 | 338 | 0.08 | Why? |
| Drug Discovery | 2 | 2018 | 3092 | 0.08 | Why? |
| Muscles | 2 | 2017 | 152 | 0.08 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.08 | Why? |
| Macrophage Activation | 1 | 2009 | 315 | 0.08 | Why? |
| Protein Kinase Inhibitors | 1 | 2017 | 1585 | 0.08 | Why? |
| Child | 5 | 2021 | 70012 | 0.08 | Why? |
| Cadherins | 2 | 2018 | 145 | 0.08 | Why? |
| Lung Transplantation | 1 | 2018 | 1554 | 0.08 | Why? |
| Chemotaxis, Leukocyte | 1 | 2006 | 82 | 0.08 | Why? |
| Chemokines, CXC | 1 | 2006 | 68 | 0.08 | Why? |
| Infant | 5 | 2021 | 30274 | 0.08 | Why? |
| Betacoronavirus | 3 | 2021 | 204454 | 0.08 | Why? |
| Melanoma, Experimental | 1 | 2006 | 57 | 0.08 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.08 | Why? |
| Ileum | 2 | 2018 | 233 | 0.08 | Why? |
| Diagnosis, Differential | 2 | 2017 | 7220 | 0.08 | Why? |
| Saliva | 2 | 2018 | 4679 | 0.07 | Why? |
| Retroviridae | 1 | 2005 | 49 | 0.07 | Why? |
| Disease Models, Animal | 3 | 2018 | 10998 | 0.07 | Why? |
| Viral Envelope Proteins | 1 | 2017 | 3539 | 0.07 | Why? |
| Diagnostic Tests, Routine | 1 | 2016 | 2643 | 0.07 | Why? |
| Genome, Viral | 4 | 2021 | 13157 | 0.07 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.07 | Why? |
| Virus Shedding | 2 | 2018 | 5834 | 0.07 | Why? |
| Public Health | 2 | 2021 | 16359 | 0.07 | Why? |
| Dengue | 1 | 2017 | 1565 | 0.07 | Why? |
| Spike Glycoprotein, Coronavirus | 5 | 2021 | 37182 | 0.07 | Why? |
| BK Virus | 1 | 2006 | 135 | 0.07 | Why? |
| Ganciclovir | 1 | 2005 | 97 | 0.07 | Why? |
| Anti-HIV Agents | 1 | 2017 | 2209 | 0.07 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.07 | Why? |
| Vero Cells | 2 | 2018 | 14117 | 0.07 | Why? |
| Dose-Response Relationship, Drug | 3 | 2018 | 3776 | 0.07 | Why? |
| Microbial Sensitivity Tests | 3 | 2017 | 2886 | 0.07 | Why? |
| HeLa Cells | 2 | 2018 | 1303 | 0.07 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2017 | 2483 | 0.07 | Why? |
| Fibroblasts | 2 | 2019 | 839 | 0.06 | Why? |
| Molecular Structure | 3 | 2018 | 1539 | 0.06 | Why? |
| Infection Control | 1 | 2012 | 23131 | 0.06 | Why? |
| Serologic Tests | 1 | 2017 | 4359 | 0.06 | Why? |
| HLA Antigens | 1 | 2009 | 830 | 0.06 | Why? |
| Viral Nonstructural Proteins | 1 | 2021 | 4810 | 0.06 | Why? |
| Staphylococcus aureus | 1 | 2009 | 844 | 0.06 | Why? |
| Immunohistochemistry | 2 | 2007 | 2275 | 0.06 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.06 | Why? |
| Aged | 9 | 2021 | 215776 | 0.06 | Why? |
| Gene Expression Regulation, Viral | 2 | 2019 | 925 | 0.06 | Why? |
| Polymorphism, Genetic | 1 | 2009 | 1074 | 0.06 | Why? |
| Vaginal Smears | 1 | 2002 | 89 | 0.06 | Why? |
| Liver Transplantation | 1 | 2018 | 2864 | 0.06 | Why? |
| Models, Theoretical | 1 | 2021 | 6659 | 0.06 | Why? |
| Cell Survival | 2 | 2018 | 1581 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.06 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.06 | Why? |
| Colposcopy | 1 | 2002 | 89 | 0.06 | Why? |
| Binding Sites | 3 | 2020 | 6201 | 0.06 | Why? |
| Travel | 2 | 2018 | 7220 | 0.06 | Why? |
| Coinfection | 2 | 2018 | 6820 | 0.05 | Why? |
| Structure-Activity Relationship | 2 | 2018 | 2219 | 0.05 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.05 | Why? |
| Viral Load | 3 | 2018 | 15850 | 0.05 | Why? |
| Adenoma | 1 | 2003 | 215 | 0.05 | Why? |
| Pan troglodytes | 1 | 2020 | 157 | 0.05 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 502 | 0.05 | Why? |
| Liver | 1 | 2015 | 4007 | 0.05 | Why? |
| Staphylococcal Infections | 1 | 2009 | 1099 | 0.05 | Why? |
| Prevalence | 3 | 2017 | 25773 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2017 | 11367 | 0.05 | Why? |
| Asia, Southeastern | 1 | 2021 | 390 | 0.05 | Why? |
| Models, Molecular | 3 | 2018 | 7616 | 0.05 | Why? |
| Sequence Homology | 1 | 2021 | 448 | 0.05 | Why? |
| Vagina | 1 | 2002 | 327 | 0.05 | Why? |
| Mice, Inbred C57BL | 3 | 2018 | 5542 | 0.05 | Why? |
| NG-Nitroarginine Methyl Ester | 1 | 2018 | 6 | 0.05 | Why? |
| Clodronic Acid | 1 | 2018 | 10 | 0.05 | Why? |
| Carbon | 1 | 2021 | 269 | 0.05 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.05 | Why? |
| Occupational Exposure | 1 | 2017 | 4742 | 0.05 | Why? |
| Reactive Nitrogen Species | 1 | 2018 | 36 | 0.05 | Why? |
| Nitrobenzenes | 1 | 2017 | 12 | 0.05 | Why? |
| Streptomycin | 1 | 2017 | 8 | 0.05 | Why? |
| Cell Transformation, Viral | 1 | 2018 | 21 | 0.05 | Why? |
| Alcohol Oxidoreductases | 1 | 2017 | 14 | 0.05 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.05 | Why? |
| Intracellular Space | 1 | 2018 | 60 | 0.05 | Why? |
| DNA-Directed DNA Polymerase | 1 | 2018 | 47 | 0.04 | Why? |
| Drug Screening Assays, Antitumor | 1 | 2018 | 138 | 0.04 | Why? |
| Orphan Drug Production | 1 | 2018 | 31 | 0.04 | Why? |
| Position-Specific Scoring Matrices | 1 | 2017 | 3 | 0.04 | Why? |
| Bacterial Adhesion | 1 | 2017 | 69 | 0.04 | Why? |
| Receptors, Chemokine | 1 | 2018 | 56 | 0.04 | Why? |
| HIV Long Terminal Repeat | 1 | 2017 | 16 | 0.04 | Why? |
| Adaptor Proteins, Vesicular Transport | 1 | 2018 | 88 | 0.04 | Why? |
| Arthropod Vectors | 1 | 2017 | 35 | 0.04 | Why? |
| Drug Stability | 1 | 2018 | 236 | 0.04 | Why? |
| Bile | 1 | 2017 | 56 | 0.04 | Why? |
| Endonucleases | 1 | 2017 | 68 | 0.04 | Why? |
| Protein Binding | 3 | 2020 | 11430 | 0.04 | Why? |
| Gentamicins | 1 | 2017 | 76 | 0.04 | Why? |
| Sp1 Transcription Factor | 1 | 2017 | 33 | 0.04 | Why? |
| Inflammation Mediators | 1 | 2009 | 2654 | 0.04 | Why? |
| Protein Domains | 2 | 2020 | 6563 | 0.04 | Why? |
| HIV Reverse Transcriptase | 1 | 2017 | 104 | 0.04 | Why? |
| Isoniazid | 1 | 2017 | 105 | 0.04 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.04 | Why? |
| Hepatitis Antibodies | 1 | 2017 | 100 | 0.04 | Why? |
| Retrospective Studies | 3 | 2018 | 105322 | 0.04 | Why? |
| Receptors, CCR5 | 2 | 2011 | 186 | 0.04 | Why? |
| DNA Replication | 1 | 2017 | 121 | 0.04 | Why? |
| Biomechanical Phenomena | 1 | 2017 | 291 | 0.04 | Why? |
| Cytoplasm | 1 | 2018 | 304 | 0.04 | Why? |
| Sus scrofa | 1 | 2017 | 205 | 0.04 | Why? |
| Phylogeny | 3 | 2021 | 13341 | 0.04 | Why? |
| ErbB Receptors | 1 | 2018 | 320 | 0.04 | Why? |
| Species Specificity | 1 | 2020 | 1356 | 0.04 | Why? |
| Protein Transport | 1 | 2018 | 487 | 0.04 | Why? |
| Multilocus Sequence Typing | 1 | 2017 | 264 | 0.04 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2018 | 640 | 0.04 | Why? |
| Proteins | 1 | 2004 | 921 | 0.04 | Why? |
| AIDS-Related Opportunistic Infections | 1 | 2018 | 260 | 0.04 | Why? |
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2015 | 8 | 0.04 | Why? |
| Liver Cirrhosis, Experimental | 1 | 2015 | 7 | 0.04 | Why? |
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2015 | 9 | 0.04 | Why? |
| Vaccine Potency | 1 | 2017 | 339 | 0.04 | Why? |
| Blood Stains | 1 | 1995 | 4 | 0.04 | Why? |
| Liposomes | 1 | 2018 | 334 | 0.04 | Why? |
| Interleukin-4 | 1 | 2017 | 367 | 0.04 | Why? |
| Chemical and Drug Induced Liver Injury, Chronic | 1 | 2015 | 11 | 0.04 | Why? |
| Chemokine CCL2 | 1 | 2018 | 389 | 0.04 | Why? |
| HIV Integrase Inhibitors | 1 | 2017 | 173 | 0.04 | Why? |
| Smokers | 1 | 2021 | 550 | 0.04 | Why? |
| Reverse Transcriptase Inhibitors | 1 | 2017 | 309 | 0.04 | Why? |
| Pluripotent Stem Cells | 1 | 2017 | 167 | 0.04 | Why? |
| Genetic Engineering | 1 | 2017 | 325 | 0.04 | Why? |
| Rifampin | 1 | 2017 | 276 | 0.04 | Why? |
| Oligonucleotide Array Sequence Analysis | 1 | 2017 | 343 | 0.04 | Why? |
| Cell Death | 1 | 2017 | 536 | 0.04 | Why? |
| Pericardium | 1 | 2017 | 228 | 0.04 | Why? |
| Markov Chains | 1 | 2017 | 502 | 0.04 | Why? |
| Arginine | 1 | 2018 | 377 | 0.04 | Why? |
| Adenocarcinoma | 1 | 2002 | 651 | 0.04 | Why? |
| DNA-Binding Proteins | 1 | 2018 | 469 | 0.04 | Why? |
| Antibodies, Viral | 2 | 2018 | 51949 | 0.04 | Why? |
| Vaccines, Conjugate | 1 | 2017 | 328 | 0.04 | Why? |
| Oseltamivir | 1 | 2019 | 583 | 0.04 | Why? |
| Genital Neoplasms, Female | 1 | 2002 | 718 | 0.04 | Why? |
| RNA, Messenger | 1 | 2009 | 5131 | 0.04 | Why? |
| Genotype | 2 | 2017 | 4697 | 0.04 | Why? |
| Virus Assembly | 1 | 2018 | 438 | 0.04 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.03 | Why? |
| Piperazines | 1 | 2017 | 445 | 0.03 | Why? |
| Vancomycin | 1 | 2017 | 328 | 0.03 | Why? |
| Homeodomain Proteins | 1 | 2015 | 93 | 0.03 | Why? |
| Pneumonia, Viral | 2 | 2021 | 243684 | 0.03 | Why? |
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 436 | 0.03 | Why? |
| Quality-Adjusted Life Years | 1 | 2017 | 511 | 0.03 | Why? |
| Cell Line, Tumor | 2 | 2018 | 3608 | 0.03 | Why? |
| Gene Expression Profiling | 2 | 2017 | 3788 | 0.03 | Why? |
| Protein Subunits | 1 | 2017 | 755 | 0.03 | Why? |
| Fungi | 1 | 2017 | 471 | 0.03 | Why? |
| Epitopes, T-Lymphocyte | 2 | 2021 | 2262 | 0.03 | Why? |
| Cats | 1 | 2020 | 1890 | 0.03 | Why? |
| Autoimmunity | 1 | 2021 | 841 | 0.03 | Why? |
| Open Reading Frames | 1 | 2021 | 1898 | 0.03 | Why? |
| Genotyping Techniques | 1 | 2016 | 360 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Circular Dichroism | 1 | 2013 | 154 | 0.03 | Why? |
| Apoptosis | 1 | 2004 | 2335 | 0.03 | Why? |
| Sequence Deletion | 1 | 2018 | 674 | 0.03 | Why? |
| Genetic Markers | 1 | 2015 | 318 | 0.03 | Why? |
| Carcinoma, Squamous Cell | 1 | 2002 | 902 | 0.03 | Why? |
| Drug Resistance, Microbial | 1 | 2017 | 419 | 0.03 | Why? |
| Pilot Projects | 1 | 2005 | 5182 | 0.03 | Why? |
| Immunoglobulins | 1 | 2018 | 811 | 0.03 | Why? |
| Influenza B virus | 1 | 2019 | 815 | 0.03 | Why? |
| Water | 1 | 2017 | 765 | 0.03 | Why? |
| China | 1 | 2019 | 50654 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Ligands | 1 | 2017 | 1300 | 0.03 | Why? |
| Interleukin-1beta | 1 | 2017 | 992 | 0.03 | Why? |
| Immunoglobulin G | 4 | 2018 | 21571 | 0.03 | Why? |
| Colon | 1 | 2017 | 669 | 0.03 | Why? |
| Streptococcus pneumoniae | 1 | 2017 | 827 | 0.03 | Why? |
| Urine | 1 | 2014 | 469 | 0.03 | Why? |
| Linear Models | 1 | 2018 | 1914 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.03 | Why? |
| Respiratory Mucosa | 1 | 2020 | 1522 | 0.03 | Why? |
| Diterpenes | 1 | 2013 | 157 | 0.03 | Why? |
| Coronavirus | 1 | 2021 | 18339 | 0.03 | Why? |
| Bayes Theorem | 1 | 2021 | 3237 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2017 | 1638 | 0.03 | Why? |
| Coronavirus Infections | 1 | 2019 | 253789 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2016 | 11559 | 0.03 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2018 | 2689 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2018 | 2134 | 0.03 | Why? |
| Interleukin-10 | 1 | 2017 | 1409 | 0.03 | Why? |
| Limit of Detection | 1 | 2018 | 2698 | 0.03 | Why? |
| Rats | 1 | 2018 | 2764 | 0.03 | Why? |
| Dengue Virus | 1 | 2017 | 910 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2018 | 9091 | 0.03 | Why? |
| Lipids | 1 | 2017 | 1079 | 0.03 | Why? |
| Pregnancy | 3 | 2018 | 23879 | 0.02 | Why? |
| Nucleic Acid Conformation | 1 | 2013 | 621 | 0.02 | Why? |
| Up-Regulation | 1 | 2018 | 2249 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2021 | 6049 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2004 | 4545 | 0.02 | Why? |
| Sexual and Gender Minorities | 1 | 2018 | 1019 | 0.02 | Why? |
| Simplexvirus | 1 | 1989 | 124 | 0.02 | Why? |
| Swine | 1 | 2017 | 3352 | 0.02 | Why? |
| Tissue Donors | 1 | 2018 | 1679 | 0.02 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2006 | 6670 | 0.02 | Why? |
| Seasons | 1 | 2021 | 4071 | 0.02 | Why? |
| Hydrazones | 1 | 1989 | 216 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2021 | 3493 | 0.02 | Why? |
| Thrombocytopenia | 1 | 2021 | 2093 | 0.02 | Why? |
| Leukocytes, Mononuclear | 1 | 2017 | 2115 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2017 | 2259 | 0.02 | Why? |
| Myelolipoma | 1 | 2006 | 2 | 0.02 | Why? |
| Protein Conformation | 1 | 2018 | 4386 | 0.02 | Why? |
| Enzyme Inhibitors | 1 | 2017 | 1881 | 0.02 | Why? |
| Adrenalectomy | 1 | 2006 | 32 | 0.02 | Why? |
| Bacteria | 1 | 2017 | 1897 | 0.02 | Why? |
| Chemokine CXCL12 | 1 | 2006 | 74 | 0.02 | Why? |
| Ovalbumin | 1 | 2006 | 84 | 0.02 | Why? |
| Cost of Illness | 1 | 2017 | 1903 | 0.02 | Why? |
| Cross Reactions | 1 | 2017 | 4374 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2018 | 2585 | 0.02 | Why? |
| Receptors, CXCR4 | 1 | 2006 | 83 | 0.02 | Why? |
| Antibodies, Bacterial | 1 | 2009 | 510 | 0.02 | Why? |
| Shc Signaling Adaptor Proteins | 1 | 2004 | 1 | 0.02 | Why? |
| Diarrhea | 1 | 2017 | 2743 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Inflammation | 2 | 2018 | 13255 | 0.02 | Why? |
| Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 2004 | 11 | 0.02 | Why? |
| Molecular Dynamics Simulation | 1 | 2018 | 4155 | 0.02 | Why? |
| Community-Acquired Infections | 1 | 2017 | 2328 | 0.02 | Why? |
| Cancer Vaccines | 1 | 2006 | 136 | 0.02 | Why? |
| Dose-Response Relationship, Immunologic | 1 | 2006 | 593 | 0.02 | Why? |
| Oxidants | 1 | 2004 | 72 | 0.02 | Why? |
| Cytotoxicity, Immunologic | 1 | 2006 | 287 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.02 | Why? |
| Adrenal Hyperplasia, Congenital | 1 | 2003 | 24 | 0.02 | Why? |
| Immunoblotting | 1 | 2004 | 180 | 0.02 | Why? |
| Jurkat Cells | 1 | 2004 | 273 | 0.02 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.02 | Why? |
| Feces | 1 | 2017 | 4235 | 0.02 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.02 | Why? |
| Europe | 1 | 2020 | 12702 | 0.02 | Why? |
| Models, Statistical | 1 | 2021 | 5312 | 0.02 | Why? |
| Biosensing Techniques | 1 | 2017 | 2116 | 0.02 | Why? |
| Liver Cirrhosis | 1 | 2015 | 1810 | 0.02 | Why? |
| Protein Isoforms | 1 | 2004 | 347 | 0.02 | Why? |
| Cushing Syndrome | 1 | 2003 | 76 | 0.02 | Why? |
| Computational Biology | 1 | 2018 | 4514 | 0.02 | Why? |
| Virulence | 1 | 2009 | 2172 | 0.01 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 7868 | 0.01 | Why? |
| Asymptomatic Diseases | 1 | 2014 | 3444 | 0.01 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2006 | 552 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.01 | Why? |
| Transplant Recipients | 1 | 2018 | 4982 | 0.01 | Why? |
| Immunotherapy, Adoptive | 1 | 2006 | 524 | 0.01 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.01 | Why? |
| Tuberculosis | 1 | 2017 | 2895 | 0.01 | Why? |
| Antigens, Viral | 1 | 2017 | 6298 | 0.01 | Why? |
| Receptors, Antigen, T-Cell | 1 | 2006 | 760 | 0.01 | Why? |
| Treatment Outcome | 2 | 2017 | 51732 | 0.01 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.01 | Why? |
| Hydrogen Peroxide | 1 | 2004 | 680 | 0.01 | Why? |
| Mice, Transgenic | 1 | 2006 | 2739 | 0.01 | Why? |
| Cell Proliferation | 1 | 2006 | 1973 | 0.01 | Why? |
| Immunoglobulin A | 1 | 2009 | 3567 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Tamoxifen | 1 | 1977 | 83 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 13720 | 0.01 | Why? |
| Polymerase Chain Reaction | 2 | 2006 | 6740 | 0.01 | Why? |
| Disease Progression | 1 | 2015 | 13580 | 0.01 | Why? |
| Zidovudine | 1 | 1995 | 63 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Forensic Medicine | 1 | 1995 | 116 | 0.01 | Why? |
| Hydrocortisone | 1 | 2003 | 1790 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.01 | Why? |
| Prognosis | 1 | 2014 | 32490 | 0.01 | Why? |
| Models, Chemical | 1 | 1989 | 332 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2015 | 48226 | 0.00 | Why? |
| Sex Factors | 1 | 2003 | 11014 | 0.00 | Why? |
| Glycosylation | 1 | 1989 | 1255 | 0.00 | Why? |
| Breast Neoplasms | 1 | 1977 | 3633 | 0.00 | Why? |
| Tomography, X-Ray Computed | 1 | 2003 | 25144 | 0.00 | Why? |
| Menopause | 1 | 1977 | 136 | 0.00 | Why? |
| Neoplasm Metastasis | 1 | 1977 | 682 | 0.00 | Why? |